US Customs Ruling (CROSS)
 HS Code : | | |
|---|
 HTS Code : | | |
|---|
| CAS Number : | |
|---|
Ruling Number :
Issuing Country : UNITED STATES
Date Of Issue : 2022-11-21T00:00:00
Trilaciclib Dihydrochloride (CAS No. 1977495-97-8)
Trilaciclib Dihydrochloride is a kinase inhibitor indicated to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive-stage small cell lung cancer
Description : Trilaciclib Dihydrochloride and Ruxolitinib Phosphate in bulk form
Please importantly note that only the relevant portion of the related US Ruling (Cross) is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
Source : US Customs Ruling (CROSS)
source link :